DTIL
NASDAQ · Biotechnology
Precision Biosciences Inc
$5.42
-0.60 (-9.97%)
Open$5.95
Previous Close$6.02
Day High$5.95
Day Low$5.41
52W High$8.82
52W Low$3.53
Volume—
Avg Volume466.7K
Market Cap161.71M
P/E Ratio—
EPS$-5.13
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+466.2% upside
Current
$5.42
$5.42
Target
$30.69
$30.69
$21.79
$30.69 avg
$37.55
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 66.26M | 59.73M | 15.69M |
| Net Income | -88,418,590 | -71,735,987 | 557.5K |
| Profit Margin | -133.5% | -126.8% | 3.6% |
| EBITDA | -77,366,576 | -66,256,420 | 726.6K |
| Free Cash Flow | — | — | 441.5K |
| Rev Growth | +10.9% | +10.9% | -7.6% |
| Debt/Equity | 0.24 | 0.24 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |